Cover Image
市場調查報告書

EpiCast Report:注意缺陷多動障礙(簡稱過動症) (ADHD) - 疫性學預測

EpiCast Report: Attention-Deficit/Hyperactivity Disorder - Epidemiology Forecast to 2024

出版商 GlobalData 商品編碼 392614
出版日期 內容資訊 英文 58 Pages
訂單完成後即時交付
價格
Back to Top
EpiCast Report:注意缺陷多動障礙(簡稱過動症) (ADHD) - 疫性學預測 EpiCast Report: Attention-Deficit/Hyperactivity Disorder - Epidemiology Forecast to 2024
出版日期: 2016年10月14日 內容資訊: 英文 58 Pages
簡介

本報告提供全球主要7個市場的注意缺陷多動障礙(簡稱過動症) (ADHD)的診斷病例數的變化的相關調查,今後的預測,疾病的背景,風險要素和並存症,各年齡、性別、感染場所的診斷病例數、預測等相關彙整。

第1章 目錄

第2章 流行病學

  • 疾病的背景
  • 風險因素、合併症
  • 全球趨勢
    • 美國
    • EU5個國家
    • 日本
  • 預測手法
    • 使用來源
    • 預測的前提條件、手法
    • 未使用來源
  • ADHD的流行病學的預測
    • ADHD的診斷病例數
    • ADHD的診斷病例數:各年齡
    • ADHD的診斷病例數:性別
    • ADHD的標準診斷案例:各年齡
    • ADHD的診斷病例數:各子類型
  • 議論
    • 流行病學的預測的考察
    • 分析的限制
    • 分析的優勢

第3章 附錄

圖表清單

目錄
Product Code: GDHCER126-16

Attention-deficit/hyperactivity disorder (ADHD) is a common childhood disorder that can continue into adolescence and adulthood (Rowland et al., 2002; Visser et al., 2014). Symptoms include higher than normal levels of impulsivity and inattention that impair an individual's ability to function properly in various settings, such as school or work. In the published literature, studies show a greater number of boys being diagnosed with ADHD compared with girls, with male to female ratios reported to range from 3:1 to 9:1, dependent on the study setting, such as in the general population or clinics (Chhabildas et al., 2001). Some studies report the worldwide prevalence of ADHD to be between 5.29-7.1% in children and adolescents, and 3.4% in adults.

There are three distinct subtypes of ADHD identified in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV): predominantly inattentive type (ADHD-I), predominantly hyperactive-impulsive type (ADHD-H), and combined type (ADHD-C) (Willcutt, 2012). Individuals with the ADHD-I subtype display symptoms that are best described by the inattentive category only, whereas individuals with ADHD-H display symptoms that are best described by the hyperactive-impulsive category only.

Epidemiologists forecast the diagnosed prevalent cases of ADHD in the 7MM to grow by 2.86% per year over the next 10 years, from 26,540,792 cases in 2014 to 34,129,001 cases in 2024. In the 7MM, the US will have the highest number of diagnosed prevalent cases throughout the forecast period, with 21,217,302 cases in 2014 and 28,833,163 cases in 2024. In the 7MM, the age group 18 years and older had the highest number of diagnosed prevalent cases of ADHD in 2014, contributing 18,870,635 cases, consisting of 71.10% of the total.

Across the 7MM, the diagnosed prevalent cases of ADHD are higher in men compared to women, with 17,153,298 (64.63%) cases occurring in men and 9,387,494 (35.37%) cases occurring in women in 2014. The ADHD subtype in children and adolescents with the highest number of diagnosed prevalent cases was ADHD-I, with 3,175,915 cases or 41.43% of the total in the 7MM in 2014, while the ADHD subtype in adults with the highest number of diagnosed prevalent cases was ADHD-C, with 10,770,130 cases or 57.07% of the total.

The report "EpiCast Report: Attention-Deficit/Hyperactivity Disorder - Epidemiology Forecast to 2024" provide an overview of the risk factors and global trends of MDD in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiology forecast of 12-month total prevalent cases of MDD segmented by age (18-19 years, in five-year increments from ages 20-84 years, and ending at ages 85 years and older), sex, and severity in these seven markets. Moreover, this report providing expert analysis of disease trends in the 7MM.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Epidemiology

  • 2.1. Disease Background
  • 2.2. Risk Factors and Comorbidities
  • 2.3. Global Trends
    • 2.3.1. US
    • 2.3.2. 5EU
    • 2.3.3. Japan
  • 2.4. Forecast Methodology
    • 2.4.1. Sources Used Tables
    • 2.4.2. Forecast Assumptions and Methods
    • 2.4.3. Sources Not Used
  • 2.5. Epidemiological Forecast for ADHD (2014-2024)
    • 2.5.1. Diagnosed Prevalent Cases of ADHD
    • 2.5.2. Age-Specific Diagnosed Prevalent Cases of ADHD
    • 2.5.3. Sex-Specific Diagnosed Prevalent Cases of ADHD
    • 2.5.4. Age-Standardized Prevalence of ADHD
    • 2.5.5. Diagnosed Prevalent Cases of ADHD by Subtype
  • 2.6. Discussion
    • 2.6.1. Epidemiological Forecast Insight
    • 2.6.2. Limitations of the Analysis
    • 2.6.3. Strengths of the Analysis

3. Appendix

  • 3.1. Bibliography
  • 3.2. About the Authors
    • 3.2.1. Epidemiologists
    • 3.2.2. Managing Epidemiologists
    • 3.2.3. Global Director of Therapy Analysis and Epidemiology
  • 3.3. About GlobalData
  • 3.4. About EpiCast
  • 3.5. Disclaimer

List of Tables

  • Table 1: Risk Factors and Comorbidities for ADHD
  • Table 2: 7MM, Sources of Epidemiological Data Used to Forecast Diagnosed Prevalent Cases of ADHD
  • Table 3: 7MM, Sources of Epidemiological Data Used to Forecast Diagnosed Prevalent Cases of ADHD by Subtype, Ages 3?17 Years
  • Table 4: 7MM, Sources of Epidemiological Data Used to Forecast Diagnosed Prevalent Cases of ADHD by Subtype, Ages ≥18 Years
  • Table 5: 7MM, Sources Not Used in Epidemiological Analysis of ADHD
  • Table 6: 7MM, Diagnosed Prevalent Cases of ADHD, Both Sexes, Ages ≥3 Years, Select Years, 2014-2024
  • Table 7: 7MM, Age-Specific Diagnosed Prevalent Cases of ADHD, Both Sexes, N (Row%), 2014
  • Table 8: 7MM, Sex-Specific Diagnosed Prevalent Cases of ADHD, Ages ≥3 Years, N (Row %), 2014
  • Table 9: 7MM, Diagnosed Prevalent Cases of ADHD, by Subtype, Ages 3-17 Years, Children and Adolescents, N (Row %), 2014
  • Table 10: 7MM, Diagnosed Prevalent Cases of ADHD, by Subtype, Ages ≥18 Years, Adults, N (Row %), 2014

List of Figures

  • Figure 1: 7MM, Diagnosed Prevalent Cases of ADHD, Both Sexes, Ages ≥3 Years, Selected Years, 2014-2024
  • Figure 2: 7MM, Age-Specific Diagnosed Prevalent Cases of ADHD, Both Sexes, 2014
  • Figure 3: 7MM, Sex-Specific Diagnosed Prevalent Cases of ADHD, Ages ≥3 Years, 2014
  • Figure 4: 7MM, Age-Standardized Diagnosed Prevalence of ADHD, Ages ≥3 Years , 2014
  • Figure 5: 7MM, Diagnosed Prevalent Cases of ADHD, by Subtype, Ages 3-17 Years, Children and Adolescents, N, 2014
  • Figure 6: 7MM, Diagnosed Prevalent Cases of ADHD, by Subtype, Ages ≥18 Years, Adults, N, 2014
Back to Top